Encompass Health Reports Strong Third Quarter Revenue Growth

BIRMINGHAM, Ala., Oct. 28, 2026 /CourierPR/ -- Encompass Health, the largest owner and operator of inpatient rehabilitation hospitals in the United States, reported strong financial results for the third quarter ended September 30, 2026. Revenue increased by 8.9%, and Adjusted EBITDA grew by 15.5%, according to the company's press release.

This growth reflects the company's commitment to meeting the growing demand for high-quality inpatient rehabilitation services.

During the first nine months of 2026, Encompass Health expanded its national footprint by opening four new hospitals, adding a total of 189 beds, and increasing capacity in existing hospitals by 85 beds. These additions underscore the company's ongoing investment in its infrastructure to support the increasing need for inpatient rehabilitation services.

In an effort to provide further guidance, Encompass Health increased its full-year financial outlook. The company will host an investor conference call at 10:00 a.m. Eastern Time on Thursday, October 29, 2026, to discuss its third-quarter results. The call can be accessed by dialing 833 354-6854 and providing the conference ID EHCQ326. International callers should dial 785 838-9343 and use the same conference ID.

Encompass Health operates 179 hospitals across 39 states and Puerto Rico, providing high-quality, compassionate rehabilitative care for patients recovering from major injuries or illnesses. The company's financial data for the quarter also revealed that net cash used in investing activities was $241.6 million, primarily due to capital expenditures. Net cash used in financing activities was $153.7 million, mainly from repurchases of common stock, distributions to noncontrolling interests, and cash dividends paid on common stock.

For the nine months ended September 30, 2025, net cash used in investing activities was $627.3 million, with capital expenditures being the primary driver. Net cash used in financing activities during the same period was $333.1 million, mainly from repurchases of common stock, distributions to noncontrolling interests, and cash dividends paid on common stock.

Encompass Health's press release is available on the company's website, along with the supplemental information posted for reference during the earnings call. The full details of the financial guidance and the reasons for not providing guidance for certain GAAP measures are available in the company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, and the Current Report on Form 8-K filed on October 28, 2026.